Objectives: To document and quantify drug use in white veal calves, an intensive livestock production system where multidrug resistance is abundantly present.
Introduction
Antimicrobial resistance is one of the leading health concerns in human and veterinary medicine worldwide. 1 Within the different animal husbandry systems, the highest levels of antimicrobial resistance are found in pigs, poultry and veal calves. 2 -8 These intensively reared livestock production animals receive multiple antimicrobial group medications. 9, 10 Transfer to humans, eventually leading to therapy failure, might occur through direct contact with live animals or indirectly via contaminated meat or the environment. 11 -13 A clear association between antimicrobial drug use and the appearance of antimicrobial resistance has been demonstrated under different conditions. 14 -18 Also, underdosing has been documented as a risk factor for the development of antimicrobial resistance.
Knowledge on antimicrobial consumption in veal calves is of particular interest, since the prevalence of methicillin-resistant Staphylococcus aureus [MRSA (ST398)] at the herd level is by far the highest (88%) among European livestock production systems and 33% of veal producers are MRSA positive. 27 Also, there is a growing interest in the use of (non-)steroidal antiinflammatory drugs [(N)SAIDs] as an additional or replacement therapy for antimicrobials in veal calves. Despite this evolution, there are hardly any studies documenting and quantifying the current use of non-antimicrobial drugs in veterinary medicine. 28 Therefore, the objectives of the present study were as follows: (i) to describe and quantify group and individual antimicrobial and anti-inflammatory drug use; and (ii) to determine risk factors for antimicrobial use and deviation from norm-dosing (leaflet recommendations) in group treatments at the cohort level.
Methods

Study design
The study population consisted of veal calf herds located in Flanders (northern Belgium), which were in compliance with the Belgian Controlled Veal (BCV) label. The sampling frame was the list of veal herds in Flanders officially registered in the Belgian cattle registration system (SANITEL, Animal Health Service-Flanders). Of the 295 veal herds in Belgium, 285 herds (97%) are situated in Flanders and 271 herds (95%) complied with the BCV label. Because of the intensive registration, regular visits and continuous reporting required in the fulfilment of this survey, farms were conveniently selected to assure optimal collaboration of the producers. Selection criteria included the willingness to keep detailed registration records on diseases and treatments, and allowing the use of all farm data, as available in the Belgian registration system (SANITEL). Selection was independent of any disease history and for logistic reasons the farms were gradually initiated in the study between October 2007 and October 2009. The study group consisted of 15 production cohorts following 15 veal herds, which were stratified for breed {5 production cohorts per breed: dairy [Holstein Friesian (HF)], beef [Belgian Blue (BB)] and crossbreeds (HF×BB), respectively}. A production cohort was defined as one all-in all-out production cycle. One herd can have different production cohorts at the same time, but here only one production cohort per herd was included as the primary epidemiological unit of interest. The study period included the complete production cycle, from arrival to slaughter. Veal production in Europe is typically integrated. An integration is defined as a company that combines all steps of the production chain by having its own feed plant and slaughterhouse, and by placing its calves in veal herds owned by producers that fatten these calves for this integration on contract. Calves belonging to the same production cohort were housed in the same stable. All calves were individually housed during the first 6 weeks, after which they were housed in groups of six animals on average (range: 2 -8), on slatted floors in compliance with Belgian legislation. None of the calves was vaccinated.
Data collection
Herds were visited at calf arrival and provided with pre-printed treatment record forms. All individually administered treatments (both oral and parenteral) were recorded daily on these forms by the producer. The treatment data recorded consisted of calf identification (ear tag), drug name, dose (mL) and administration route. The following treatment indications were given as options on the registration form: respiratory disease, diarrhoea, (idiopathic) peritonitis, acute ruminal disorder, ruminal drinking, otitis, arthritis, omphalitis, laryngeal necrobacillosis, nervous symptoms and miscellaneous. All treatments, individually administered by a veterinarian, were recorded on the treatment forms as well. Not included as treatments were the administration of iron (to control the anaemic state of the calves), electrolytes, pectins or probiotics. For group treatments, the indication, drug name, dose (mg/kg body weight) and prescribed therapy duration (length in days) were registered on a separate form by the farmer. A group treatment was defined as each prophylactic or metaphylactic administration of a drug to a minimum of one complete compartment. Prophylactic use was defined as each treatment of healthy animals to prevent disease from occurring. Metaphylactic use was defined as the simultaneous treatment in a shared compartment of clinically healthy animals and animals that showed clinical symptoms of the disease. 29 After slaughter, the collected written treatment records were compared with the mandatory prescription documents (administration records of the veterinarian and the official medication register of the farmer), which are under the supervision of the federal agency responsible for food chain safety. Herds were visited between four and eight times by the same investigator to check compliance with the registration system.
Processing of antimicrobial and anti-inflammatory consumption records
Group and individual treatment data were entered in a relational database (Access 2010, Microsoft w Inc., Redmond, WA, USA). The volumes of antimicrobials and anti-inflammatory drugs administered were converted to mg of active substance per kg of live body weight. Drug consumption records were processed using three units of measurements, outlined in detail below: the animal defined daily dose (ADD), the prescribed daily dose (PDD) and the used daily dose (UDD). 9,10,17,20,22 -24,26,30,31 The ADD is defined as the average maintenance dose for the main indication in a specified species, e.g. 30 mg/kg oxytetracycline for bovine respiratory disease. 31 The ADD values (mg of drug per kg of live weight) were estimated for each antimicrobial and anti-inflammatory substance, based on the dosage recommendations of the Belgian compendia for veterinary drugs and the drug instructions leaflets. 32 The Anatomical Therapeutic Chemical classification system for veterinary medicinal products (ATCvet) was used for antimicrobial drug identification. 21 For the combination preparations the ADD values were estimated for the main substance, with the exception of trimethoprim/sulphonamide combinations, for which the ADD was set for both compounds. 33 For long-acting preparations, the ADD was calculated from the recommended dosage into a 24 h dose, by dividing by a long-acting factor of 2 for amoxicillin, danofloxacin, florfenicol and tilmicosin, and 5 for tulathromycin.
The PDD reflects the prescribing behaviour of the veterinarian and was calculated by dividing the dosage mentioned on the official drug prescription records, delivered by the veterinarian, by the average live weight at the beginning of the treatment. For example, for bovine respiratory disease, a PDD can be 2 g of oxytetracycline per day per calf, irrespective of the exact body weight. The UDD is calculated as the amount of an antimicrobial drug administered during a given period (days) divided by the number of calves at risk and their average live weight at the beginning of the treatment. 9 In this way the UDD reflects the dose, truly administered by the producer, e.g. 18 mg/kg body weight oxytetracycline for bovine respiratory disease in a particular herd. The kg of animals at risk was determined by multiplying the number of animals present at the beginning of a given treatment by the estimated average body weight at that time. 31 Average live weight curves per week after arrival and per breed (HF, BB and HF×BB) were created, based upon the feed uptake and slaughter data of the monitored herds. Standard values for average weight at arrival (42 kg for HF, 46 kg for BB×HF and 56 kg for BB), feed conversions (0.46 kg growth/kg milk powder for HF, 0.64 Pardon et al.
for HF×BB and 0.76 for BB) and dressing percentages (55% for HF, 63% for HF×BB and 69% for BB) were obtained from the veal integrators.
The frequency of treatment was quantified by calculating the treatment incidence (TI), based upon the three definitions of defined dose explained above, namely ADD (TI ADD ), PDD (TI PDD ) and UDD (TI UDD ). 9, 10, 23 In order to be able to compare with the monitoring of antimicrobial usage in animals in the Netherlands (MARAN), the TIs based on ADD were also calculated for the standard veal calf live weight of 164 kg, as used in that report (TI ADDsw ). 34 The following formula was used to calculate TIs: Both for antimicrobials and (N)SAIDs, the PDD/ADD and UDD/ADD ratios were calculated to assess the compliance with dosing by the veterinarian or the farmer, respectively. A ratio lower or higher than 1 was considered as under-and over-dosing, respectively, taking an acceptable inaccuracy of 0.2 into account. 9 In the same way, the UDD/PDD ratio reflects to what extent the farmer actually applied the doses prescribed by the veterinarian. For the oral group treatments, TIs and the three different dosing ratios were calculated for every installed treatment, whereas for individual treatments these were calculated per drug and per indication on a weekly basis. All results are displayed as the mean (SD; median; minimum-maximum).
Statistical analysis
Cohort level predictors (n¼18) were collected through a personal interview with the producers or derived from the technical results of the cohort. These included: breed (dairy, mixed breed or beef calves); production cycle length (.196 or ≤196 days); herd location (province); region (west or east of Flanders); herd size (,600, 600-900 or .900 calves); number of cohorts per herd (1 or .1); cohort size (,300, 300-500 or .500 calves); year of arrival (2007, 2008 or 2009); season of arrival; compartmentalization (1 or .1 compartment); mortality risk of the studied cohort (low, ,3%; intermediate, 3% -6%; or high, .6%); mortality risk due to pneumonia of the studied cohort (low, ,1%; intermediate, 1%-2%; or high, .2%); identity of the veterinarian; identity of the integrator; integration size (≥50 or ,50 herds); number of caretakers (1 or .1); gender of the primary caretaker (male or female); presence of foreign calves (yes or no); and presence of other food animals (yes or no). An origin index was calculated by dividing the number of herds of origin by the number of calves that arrived at the cohort (,0.7¼few herds of origin, 0.7-0.8¼moderate or .0.8¼high) and added as a cohort level risk factor.
Risk factors for group antimicrobial use and correctness of dosing at the cohort level were identified using linear regression models with, respectively, the total TI UDD for group antimicrobial treatments and the average of the UDD/ADD ratio as continuous outcome variables. In a first step, all predictors were tested univariably. The variables with a P value of ≤0.2 were withheld for the multivariable regression model. Pearson and Spearman's r correlation coefficients were calculated, and if the correlation between two selected predictors was .0.6, only the most significant variable was retained in the model. When the log likelihood changed substantially after removal of a non-significant predictor, the predictor was retained in the model. The model was built stepwise backwards, gradually excluding the non-significant factors and finally only retaining the significant factors. Significance was set at P≤0.05. Interactions were checked for all significant main factors in the model. All models were built in S-plus 8.2 (Tibco Spotfire, Somerville, MA, USA).
Results
Quantitative and qualitative drug use
Drug use was monitored in 5853 veal calves, housed in 15 commercial veal herds, with an average herd size of 679 (SD¼ 334) calves [964 (SD ¼ 418) for dairy, 588 (SD¼ 112) for crossbreeds and 484 (SD¼ 207) for beef calves]. The herd sizes of the selected herds were comparable to the sampling frame (Student's t-test, P .0.05). The mean production length was 196 days (range: 175 -211). The individual treatment records were judged as unreliable after comparison with official treatment registration records in five cohorts. Therefore, individual drug use could only be processed for 3519 calves (10 production cohorts).
Group treatments were by far more frequently used than individual treatments (97.9% of the total use, based on UDD). All antimicrobial group treatments were orally administered, twice daily in the milk. The average number of group treatment courses per production cohort was 10+3 (range: 4 -15). Antimicrobials accounted for 82.0% (mean: 8; SD: 3; range: 4 -13) of the group treatments and non-antimicrobials (macrocyclic lactones and NSAIDs) for 18.0% (mean: 2; SD: 1; range: 1 -4). Of the antimicrobial group treatments (n¼ 126), 13.0% was used prophylactically (immediately after arrival) and 87.0% metaphylactically or as a curative measure. Most group treatments were administered in the first weeks after arrival (Figure 1 ). The most frequent indication for antimicrobial group treatment was respiratory disease (53%). Other indications were arrival prophylaxis (13%), diarrhoea (12%), dysbacteriosis (defined as non-specific bacterial enteritis) (12%), idiopathic peritonitis (7%) and enterotoxaemia (3%). In 33.3% of the antimicrobial group treatments, a combination of two antimicrobial preparations was used. The applied antimicrobial combinations by indication are given in Table 1 (Figures 2 and 3) . The most frequently used antimicrobials for group treatments were oxytetracycline (proportional TI UDD ¼ 23.7%), amoxicillin (proportional TI UDD ¼18.5%), tylosin (proportional TI UDD ¼ 17.2%) and colistin (proportional TI UDD ¼ 15.2%), which were used on 93.3% of the production cohorts ( Figure 3 and Tables 2 and 3 
2).
The main reason for underdosing was the use of oxytetracycline and tylosin for the treatment of dysbacteriosis, which was most frequently treated in the second half of the production cycle (Table 4 and Figure 1 ). Individual antimicrobial treatment was mainly injected and only accounted for 4.2% (3.4; 2.8; 1.3 -11.9) and 2.1% (1.9; 1.5; 0.5 -7.3) of the overall TI, based on ADD and UDD, respectively. (Tables 3 and 4) . Florfenicol, amoxicillin and the combination lincomycin/spectinomycin were the most frequently used individually administered antimicrobials, with respective proportional TIs of 19.0%, 15.1% and 12.2% (Table 5) . The UDD/ADD ratios for the individually administered antimicrobial drugs are given in Table 3 . For the individual administrations no detailed prescriptions of the veterinarian were available; therefore, the PDD could not be calculated. Overall, 81.8% (18/22) of the individually used antimicrobial formulations were overdosed, 13.6% were norm-dosed and 4.5% were underdosed. Only lincomycin/ spectinomycin was systematically underdosed ( production cohort were used, of which on average 6 (1.9; 6.0; 5-8) were used in oral group treatments and 10 (1.9; 10.5; 7.0-13.0) in the individual treatments.
Anti-inflammatory drugs were far less frequently used compared with antimicrobials (TI UDD ¼ 5.94). Only sodium salicylic acid was used in group treatments, to prevent shock after parenteral administration of iron dextran (13/17) and to treat respiratory disease (4/17 treatments). The main indication for the individual use of (N)SAIDs was respiratory disease. TIs of the individually used (N)SAIDs are given in Table 6 . Most administrations of NSAIDs were administered by the producers, whereas steroidals were exclusively administered by the veterinarian. Orally administered sodium salicylic acid was underdosed, whereas the individually injected (N)SAIDs were generally overdosed ( Table 6 ). The other non-antimicrobial drugs that were used in the followed cohorts included group treatments with pour-on formulations of macrocyclic lactones to treat scabies (exclusively BB) or lice, and individual administration of macrocyclic lactones, vitamin preparations, diclazuril and halofuginone.
Statistical analysis
Univariable testing delivered six significant risk factors for antimicrobial use (TI UDD ) at the P,0.2 level: season, veterinarian, integrator, integration size, herd location and region, of which the latter five were highly correlated. Of these, only the most significant variable, namely integration size, was included in the multivariable model. The size of the integration was the only variable to remain marginally significant in the final multivariable model, with cohorts from smaller integrations using a larger amount of antimicrobials in group treatments (P,0.05). The average TI UDD was 350.6 and 487.1 UDD per 1000 calves in herds belonging to large and small integrations, respectively.
Univariable testing for the UDD/ADD ratio delivered two significant variables, namely the number of caretakers and total mortality. Both variables remained significant in the final multivariable Pardon et al.
model. Cohorts with a single caretaker overdosed on average, compared with cohorts with more than one caretaker, which norm-dosed (P,0.01). The total mortality was a significant predictor (P,0.05). Cohorts with low mortality (,3%) tended to overdose, but no distinction between the three classes could be made due to lack of power. Pardon et al.
Discussion
Since not all drugs delivered to a farm are used and because treatment practices are not always in compliance with the manufacturers' instructions, the most accurate information on drug use is obtained by monitoring the end-users. 9, 35, 36 Monitoring practices at the end-user level can provide essential information on what aspects of responsible antimicrobial use are in need of specific training within a certain sector. In contrast to total drug consumption data or sales, provided by pharmaceutical companies or large distributors, the collection of end-user data is more laborious and expensive, and therefore more likely to result in insufficient data. 35 Since retrospective data collection is subject to recall bias, prospective data collection was used. For these reasons, cohorts with well-motivated producers were conveniently selected in the present study, possibly leading to selection bias. 37 Because the sample size included 5% of the population (all breeds included) with .90% of the veterinarians and integrations active in the field represented, and because the housing and feeding of white veal calves are highly standardized in Belgium, this bias is believed to be limited. Despite the drawbacks of convenience selection, the sample is assumed to be representative for the Belgian veal industry at present.
The incidence of group antimicrobial treatments (TI ADD ¼414.0 ADD per 1000 veal calves) was strikingly higher than in conventional dairy and beef cattle (6.3 and 5.4 per 1000 cattle, respectively), pigs (178.1 and 235.7 per 1000 pigs in 2003 and 2010, respectively) or poultry (121.4 per 1000 chickens) in Belgium. 9, 10, 38, 39 However, the TI based on a standard weight of a white veal calf of 164 kg, as used in the Dutch MARAN report, was much lower than the TI based on the actual live weight, namely 164.3 ADD per 1000 calves. 34 The best estimation of the TI is obtained by calculating the number of daily dosages on the basis of the best possible estimate of the average live weight at the time of treatment, 34 as was done in the present study. Due to the large variation in body weight according to age and breed in different production animal species, an applied body weight can seriously influence the calculated TIs, as was demonstrated (Figure 2 ). Another issue is what daily dose to use for the calculation of TIs. As the PDD and UDD tend to vary over time and between veterinarians and producers, the use of an internationally agreed ADD for animals is advisable in order to compare different production systems or countries. The selected ADDs influence the calculated TIs and therefore should at least be mentioned in each report.
Despite these comments on methodology, antimicrobial use in the Belgian veal industry was still twice as high as that in the Netherlands, as has been reported for pigs and poultry. 9, 10 However, it is important to note that the reported TIs for the Dutch veal industry imply both 'white' (70%) and 'rosé' veal (30%). Since rosé veal systematically receives less antimicrobials than white veal due to a different nutritional management (ruminating calves), the antimicrobial use in white veal in the Netherlands is probably higher than reported for the overall veal production in the MARAN report. The most likely explanation for the higher antimicrobial drug use in veal calves compared with in poultry and pigs is the typical organization of the veal industry. Whereas pig herds and poultry flocks are mainly closed or only combine animals from a limited number of origins, the veal industry commingles young, recently transported, highly stressed calves that originate from Table 6 . multiple farms, both domestic and foreign. The combination of these factors is known to cause a higher disease risk. 40, 41 All group treatments in veal calves were orally administered. The main reasons for the preference for orally administrable antimicrobials in the veal industry are the easy administration in the milk during the feeding routine and the low cost per calf. In contrast, a good application of individual injections requires continuous visual inspection of the calf and compliance with the prescribed treatment length, both of which are very laborious and require well-trained producers. Another important issue with individual treatment in the present study was the large number of different antimicrobials used per cohort, including the widespread use of so-defined critically important cephalosporins, fluoroquinolones, penicillins and macrolides. 42 Veterinarians still tended to administer fluoroquinolones and long-acting macrolides themselves, but the highest proportion of these antimicrobials was administered by the producers. The fact that thirdand fourth-generation cephalosporins were almost exclusively administered by the producers in all monitored cohorts is worrisome, but similar to the situation in North American dairy farms (85%). 24 In contrast, in Canadian cow-calf herds and American beef cattle the percentage of herds on which cephalosporins were used was much lower (16% and 3.8%, respectively). 25, 43 Fortunately, florfenicol and lincomycin/spectinomycin, two antimicrobials that are not classified as critical for human medicine, were among the most frequently used individual drugs, opening perspectives for the systematic use of injectable formulations.
The overall TI UDD was smaller than the overall TI ADD , suggesting overdosing. Nevertheless, .40% of the group antimicrobial treatments were still underdosed, as observed in pigs. 9, 39 Only amoxicillin as arrival prophylaxis was markedly overdosed. The systematic severe underdosing of oxytetracycline and tylosin when used to treat dysbacteriosis was a striking finding. An overestimation of the body weight for amoxicillin at arrival and an underestimation of the body weight in the second half of the production cycle when dysbacteriosis is most frequently treated seem the most likely explanation. However, the UDD/PDD ratio of the oral group treatments showed that producers tended to closely follow the veterinarian's prescriptions. In fact, for dysbacteriosis, lower antimicrobial dosages than for the main indication (respiratory disease) were prescribed, as was the case for enterotoxaemia. Macrolide and oxytetracycline resistances were the most frequently detected resistances in Pasteurellaceae in white veal calves in Belgium, and this is possibly related to these underdosing practices for dysbacteriosis. 4, 44 Why prescriptions by the veterinarian were overall slightly overdosed in cohorts with a single caretaker, whereas they were correctly followed in cohorts with multiple caretakers, is not completely understood. Since there was no correlation of the number of caretakers with the herd size or integration, the explanation most probably lies in other, likely socioeconomic, aspects of a more professional approach of veal farming in herds with multiple caretakers. The trend towards higher mortalities in underdosing cohorts is most likely caused by the deliberate underdosing in cohorts with high mortalities due to enterotoxaemia.
Perhaps the most exploitable finding in the present study was the trend that larger integrations used less antimicrobials. Since integration size, integration, veterinarian and region were highly correlated, this signifies an important influence of the integration as a whole on antimicrobial consumption in veal herds. It is clear that a reduction in antimicrobial drug use in the veal industry can only be achieved by reducing the number of oral antimicrobial group treatments, since this implies a high degree of metaphylactic treatments (87%). In the Netherlands, where the production system and diseases are highly similar to in Belgium, a significant reduction in antimicrobial use in veal calves has already been achieved. 34 Previous studies have shown that good economic results can be obtained with metaphylactic injection therapy with long-acting formulations only, both at arrival and when a clinical outbreak occurred. 45 -48 Also, correct dosing, instead of overdosing, is an option to reduce antimicrobial use. Because of the multifactorial nature of respiratory disorders in cattle, not only improved treatment protocols but also vaccination, correct housing, disinfection and preconditioning of the calves might further reduce antimicrobial use. 49 The use of (N)SAIDs in veal calves is currently limited. Including NSAIDs in standard individual treatment protocols could enhance both production results and animal welfare. 50, 51 However, attention should be given not to overdose NSAIDs, because of the possible toxic side effects, especially in dehydrated animals, such as diarrhoeic calves and in case of the prolonged use of sodium salicylic acid as a group treatment. 52, 53 In addition to these measures, the continuous monitoring of group and individual antimicrobial use with an electronic recording system (personal digital assistant) is recommended to guarantee accurate data input.
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Conclusions
The present study offers a benchmark for antimicrobial use in the European veal industry, based on the Belgian situation. At present, antimicrobial drug use is intensive and highly variable. Several opportunities to reduce antimicrobial use should be evaluated in future studies. The reduction of antimicrobial use in the veal industry is a joint responsibility, for which the initiative lies with the integration.
